Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
Cantor Fitzgerald
Merck
Federal Trade Commission
US Department of Justice
Farmers Insurance
QuintilesIMS

Generated: October 23, 2017

DrugPatentWatch Database Preview

Lupin Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for LUPIN PHARMS, and what generic and branded alternatives to LUPIN PHARMS drugs are available?

LUPIN PHARMS has ten approved drugs.

There is one tentative approval on LUPIN PHARMS drugs.

Summary for Applicant: Lupin Pharms

US Patents:0
Tradenames:8
Ingredients:8
NDAs:10
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Pharms
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL078466-004Feb 5, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
RIFAMPIN
rifampin
CAPSULE;ORAL090034-001Aug 21, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
PRAVASTATIN SODIUM
pravastatin sodium
TABLET;ORAL077917-003Jan 8, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL078466-005Jul 5, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
MELOXICAM
meloxicam
TABLET;ORAL077944-002Jul 19, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
RIFAMPIN
rifampin
CAPSULE;ORAL090034-002Aug 21, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL077560-002Mar 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL077560-004Mar 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
SUPRAX
cefixime
FOR SUSPENSION;ORAL065129-001Feb 23, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
SUPRAX
cefixime
FOR SUSPENSION;ORAL065355-001Apr 10, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for LUPIN PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
cefixime
for Oral Suspension500 mg/5 mL
SUPRAX
7/22/2014

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Daiichi Sankyo
Mallinckrodt
Dow
Johnson and Johnson
Covington
Merck
Chubb
Queensland Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot